Filippo Maria Cogiamanian

@policlinico.mi.it

Neuropathophysiology Unit
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Filippo Maria Cogiamanian


            Download Compact PDF  
https://researchid.co/francesca76

RESEARCH INTERESTS

Deep Brain Stimulation in Parkinson disease
83

Scopus Publications

Scopus Publications

  • Clinical usability of telephone-based cognitive screening tests in Parkinson's disease
    Angelica De Sandi, Edoardo Nicolò Aiello, Federica Verardo, Denise Mellace, Angelica Marfoli, Carlo Manzoni, Stefano Zago, Fabrizio Pisano, Gabriella Santangelo, Enrico Mailland, Eleonora Zirone, Francesca Mameli, Barbara Poletti, Filippo Cogiamanian, Roberta Ferrucci
    Journal of Parkinson S Disease, 2026
    Background Accessible screening tools are crucial for the early detection of cognitive impairment in Parkinson's disease (PD), especially in contexts where in-person assessments are not feasible. Objective To assess the clinical usability of telephone-based cognitive screening (TBCS) tools in PD patients. Methods Forty-two non-demented PD individuals and N = 103 healthy controls (HCs) underwent a TBCS battery including the Telephone Interview for Cognitive Status (TICS), the Telephone-based Frontal Assessment Battery (t-FAB) and sub-tests from the Telephone-based Verbal Fluency Battery (t-VFB) and Telephone Language Screener (TLS). PD individuals were also administered the Montreal Cognitive Assessment (MoCA) in person and assessed for behavior and cognitive-driven functional independence via caregiver-report questionnaires administered over the telephone (Neuropsychiatric Inventory, NPI and Amsterdam IADL Questionnaire – 30-item version, A-IADL-Q-30, respectively). Correlations were run to test the construct and ecological validity of TBCS tests in PD individuals; ROC analyses were run to test the capability of TBCS tests to discriminate PD individuals from HCs and PD individuals with a defective MoCA from those performing normally (PD-MCI vs. PD-CN). Results The vast majority of TBCS measures were significantly associated with the MoCA and A-IADL-Q-30 scores, supporting convergent and ecological validity, respectively; TBCS measures also diverged from the NPI. TBCS measures of global cognition and executive-attentive measures discriminated PD individuals from HCs with acceptable accuracy (AUC = 0.71–0.75), showing, by contrast, a better performance in differentiating PD-MCI from PD-CN groups (AUC = 0.74–0.89). Conclusion TBCS tests are clinimetrically sound tools for identifying cognitive deficits in PD.
  • Perilead Edema in Deep Brain Stimulation: Long-Term Outcomes and Etiologic Correlates
    Luigi G. Remore, Giorgio Fiore, Elena Pirola, Linda Borellini, Francesca Mameli, Fabiana Ruggiero, Eleonora Zirone, Roberta Ferrucci, Filippo Cogiamanian, Enrico Mailland, Antonella M. Ampollini, Giulio A. Bertani, Elena Scagliotti, Stefania E. Navone, Giovanni Marfia, Ioannis U. Isaias, Marco Locatelli
    Neuromodulation, 2026
    OBJECTIVES: Deep brain stimulation (DBS) is an effective surgical procedure for the treatment of Parkinson disease (PD) and other movement disorders. Immediate and delayed complications after DBS surgery have been described. Perilead edema (PLE) is a DBS-related complication for which the etiology remains unknown. Moreover, PLE frequency and long-term effects are subjects of ongoing debate. Our study aims to elucidate the long-term clinical and neuropsychologic effects of PLE and to find possible etiologic correlates. MATERIALS AND METHODS: We retrospectively collected clinical and neuropsychologic data from 51 patients with PD before and 1 year after DBS. PLE visualized on fluid attenuated inversion recovery magnetic resonance imaging (MRI) sequence was manually segmented. Using appropriate statistical tests, continuous and categorical variables were compared in patients with and those without PLE. A multivariate regression model was used to analyze the contribution of clinical variables to edema volume changes. RESULTS: Overall, 68.62% of patients presented with PLE at the immediate postoperative MRI. Patients with PLE were significantly older (p < 0.001) and had more frequent postoperative confusion episodes (p = 0.025). Furthermore, more microelectrode recording (MER) tracks (p < 0.001) were used in patients with PLE. Multiple MER tracks were directly correlated with edema volume and were the only significant predictors of edema volume changes in a multivariate regression model. No differences were found in other clinical and neuropsychologic variables. CONCLUSIONS: PLE is a frequent postsurgical event and may cause transient postoperative confusion. It seems linked to older age and multiple MER tracks. Although it does not influence global motor and neuropsychologic outcomes, PLE contributes to postoperative confusion episodes. To avoid PLE sequelae, using multiple MER tracks in older patients should be discouraged.
  • Triple perspective: assessing deep brain stimulation outcomes in Parkinson's disease
    Denise Mellace, Francesca Mameli, Fabiana Ruggiero, Filippo Cogiamanian, Linda Borellini, Angelica De Sandi, Angelica Marfoli, Eleonora Zirone, Enrico Mailland, Elena Pirola, Antonella M. Ampollini, Luigi G. Remore, Marco Locatelli, Alberto Priori, Sergio Barbieri, Roberta Ferrucci
    BMC Neurology, 2025
    Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for advanced Parkinson’s disease (PD), often leading to positive motor and non-motor outcomes. While objective motor improvements after DBS are well documented, less is known about how patients and all those involved in their care perceive these benefits on a subjective level. The primary aim of the study was to investigate the perception gap between patients, caregivers, and treating neurologists regarding DBS physical and psychological benefits in PD and their correlates. 25 PD patients (age 58.9 ± 8.0 years; 9 women) who underwent bilateral STN-DBS, along with their caregivers and neurologists, rated perceived psychological and physical improvements 6 months after surgery using a two-item Visual Analogue Scales (VAS, 0–10). Intraclass correlation coefficients (ICC [95% confidence interval]) were calculated to assess reliability between raters. Patients, caregivers, and neurologists reported an average improvement of about 60% in the psychological domain and over 75% in the physical domain (p < 0.001). No significant differences emerged between groups in two domains (p > 0.05). Inter-rater agreement was moderate-to-good for psychological improvement (0.74 [0.41–0.90], p < 0.001), moderate for physical improvement (0.69 [0.27–0.88], p = 0.003), and good overall (0.79 [0.50–0.92], p < 0.001). PD patients, caregivers, and neurologists largely agree on the benefits of DBS six months post-surgery, reinforcing the reliability of patient self-report in outcome assessment. Integrating patient self-reports with proxy assessments enhances the evaluation of DBS outcomes, supporting a more comprehensive and patient-centered approach to both treatment assessment and post-surgical care. ClinicalTrials.gov Identifier: NCT06329726. Registered on 26 March 2024.
  • Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant
    Micol Avenali, Carlo Alberto Artusi, Roberto Cilia, Giulia Giannini, Giada Cuconato, Alberto Albanese, Nico Golfrè Andreasi, Pietro Antenucci, Angelo Antonini, Laura Avanzino, Luca Baldelli, Anna Rita Bentivoglio, Francesco Bove, Marco Bozzali, Giovanna Calandra-Buonaura, Ilaria Cani, Valerio Carelli, Francesco Cavallieri, Antoniangela Cocco, Filippo Cogiamanian, Fabiana Colucci, Pietro Cortelli, Alesssandro De Biase, Francesca Di Biasio, Alessio Di Fonzo, Valentina D'Onofrio, Roberto Eleopra, Antonio Emanuele Elia, Valentina Fioravanti, Danilo Genovese, Andrea Guerra, Alberto Imarisio, Claudia Ledda, Marco Liccari, Chiara Longo, Leonardo Lopiano, Maria Chiara Malaguti, Rachele Malito, Francesca Mameli, Silvia Marino, Raffaella Minardi, Pierfrancesco Mitrotti, Edoardo Monfrini, Claudio Pacchetti, Carla Piano, Vittorio Rispoli, Mario Giorgio Rizzone, Luigi Michele Romito, Luisa Sambati, Mariachiara Sensi, Chiara Sorbera, Francesca Spagnolo, Cristina Tassorelli, Francesca Valentino, Franco Valzania, Roberta Zangaglia, Maurizio Zibetti, , Enza Maria Valente, Valentina Leta, Sylvie Piacentini, Ilaria Palmieri, Marta Picascia, Stefania Lalli, Paola Polverino, Paola Mandich, Roberta Marchese, Giuseppe Di Lorenzo, Amelia Brigandi, Giulia Di Lazzaro, Martina Petracca, Ilaria Trezzi, Emanuele Frattini, Alessia Fiorentino, Pietro Guaraldi
    Neurology, 2025
    BACKGROUND AND OBJECTIVES: genotype and DBS on long-term motor and nonmotor outcomes. METHODS: variant class and DBS target. RESULTS: -between <0.001 and 0.02, respectively), regardless of DBS. No relevant differences emerged on stratification for variant classes or DBS targets, up to 3 years postsurgery. DISCUSSION: Despite its retrospective design, this study supports DBS as a valid therapeutic option for GBA-PD, providing prolonged benefits on motor symptoms and quality of life. The accelerated cognitive decline observed in GBA-PD, compared with non-mutated participants, was similarly present in both operated and non-operated groups, suggesting it is driven by the genotype rather than DBS itself. CLASSIFICATION OF EVIDENCE: -associated PD.
  • The Emotional Landscape of Multiple System Atrophy: A Preliminary Personality-Based Perspective
    Eleonora Zirone, Giulia Franco, Federica Arienti, Roberta Ferrucci, Alessandro Di Maio, Giacomo Comi, Filippo Cogiamanian, Alessio Di Fonzo, Francesca Mameli
    Journal of Clinical Medicine, 2025
    Background: Multiple System Atrophy (MSA) is a rapidly progressing neurodegenerative movement disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. While its non-motor symptoms are well-documented, personality features in MSA remain underexplored. This study characterizes the personality traits of non-demented patients with MSA and explores their association with clinical variables. Methods: Twenty-six patients with MSA were assessed using the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF). Dementia was excluded by Montreal Cognitive Assessment. Descriptive statistics and non-parametric analyses were conducted to examine clinical, demographic, and MMPI-2-RF variables. Results: Patients commonly showed elevated scores in somatic domains: Somatic Complaints (39%), Malaise (58%), and Neurological Complaints (85%), as well as in internalizing emotional traits: Low Positive Emotions (39%), Introversion (46%), Suicidal Ideation (46%), and Hopelessness (54%). Externalizing behavioral traits were absent, with only 4–8% of patients showing elevations in aggression or behavioral dysfunction. Strong correlations were found between somatic and emotional traits (r = 0.656, p &lt; 0.001), and between Neurological Complaints and disease duration (r = 0.662, p &lt; 0.001). Conclusions: This exploratory study reveals a distinct personality pattern in MSA, characterized by marked suicidal ideation, emotional vulnerability with internalizing coping, and absence of externalizing behaviors. These features highlight the need for suicide risk screening, interventions to alleviate psychological suffering, and tailored multidisciplinary care. Larger, longitudinal studies are warranted to confirm these preliminary results and clarify whether these traits reflect premorbid personality, early disease manifestations, or secondary responses, as well as their prognostic and clinical relevance.
  • Letter to the Editors: Comments on “Clinical and Imaging Correlates of Medication Reduction in Globus Pallidus Stimulation for Parkinson's Disease”
    Luigi G. Remore, Filippo Cogiamanian, Ioannis U. Isaias, Marco Locatelli
    Movement Disorders Clinical Practice, 2025
    We read with great interest the paper by Di Luca et al.1 After a VTA-based analysis, the authors identified the anteromedial GPi as the stimulation site associated with supra-threshold LEDD reduction in PD patients undergoing GPi-DBS. No clinical or demographic variables significantly contributed to LEDD reduction in a multivariate logistic regression model; thus, the anatomic location was confirmed to be the only factor determining pharmacological variations in the analyzed cohort. The study has some limitations, mainly its retrospective nature, the relatively small number of patients included and the chosen threshold for LEDD reduction (ie, >30%) that was justified by literature evidence, although LEDD reduction after STN-DBS is often much more pronounced in the clinical practice as well as patients’ expectations are. Nonetheless, we think that this study is important and challenges the two main actors involved in target selection: the neurosurgeon, who should not take for granted that only stimulation of the posteroventral GPi provides motor improvement; the neurologist, who should not refrain from offering GPi-DBS to PD patients because of supposed inferior reduction in anti-parkinsonian medications. Interestingly, the results of this study contrast with a recent paper by Holland et al,2 who proposed the dorsolateral GPi as an ideal target. Specifically, stimulation of the dorsal GPi closer to GPe yielded inferior UPDRSIII ON/OFF scores, less ON dyskinesias and more pronounced LEDD reduction than GPi subcomponents distant from the medial medullary lamina (mml). Conversely, Di Luca et al1 reported sub-threshold LEDD reduction in stimulation volumes close to the mml and cited existing evidence against GPe-stimulation. We suspect that these opposing results may reflect different methodologies: Holland et al2 localized contacts with clinically available software, while Di Luca et al1 performed a VTA-based probabilistic voxel analysis. Both methods have various limitations, specifically concerning the degree of anatomic reliability. Further clinical studies with larger cohorts and possibly randomized designs are needed to clarify which surgical target is the most beneficial between the dorsal and anteromedial GPi. The paper by Di Luca et al1 has two potential clinically relevant implications. Firstly, more widespread adoption of GPi-DBS would result, if the drug-sparing effect of GPi-stimulation was confirmed. Indeed, especially European neurologists tend to reserve GPi-DBS for older and more dyskinetic PD patients, who would not tolerate abrupt drug reduction after STN-DBS.3 Secondly, the LEDD-reduction effect of GPi-stimulation would benefit the “renaissance” of lesional procedures. Di Luca et al1 cited the LEDD-sparing effect of more anteromedial targeting during classical pallidotomies, while a recent randomized trial showed promising results for MRI-guided FUS pallidotomy.4 Although drug dosages were kept constant during the follow-up period as required by the trial's protocol,4 an LEDD-reducing effect might hasten the clinical application of FUS pallidotomy. However, concerns remain about the yet-described cognitive sequelae after lesions of the limbic anteromedial GPi5 further underscored the different pathogenetic mechanisms underlying stimulation and lesioning. In conclusion, we applaud the authors for their study. We believe their work will push neurologists to overcome strict dogma in target selection and neurosurgeons to tailor the target to patients’ characteristics. (1) Research project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript Preparation: A. Writing of the first draft, B. Review and Critique. L.G.R.: 1A, 1B, 1C, 3A. F.C.: 3B. I.U.I.: 3B. M.L.: 1A, 1B, 3B. The Italian Ministry of Education and Research—MUR (“Dipartimenti di Eccellenza” Programme 2023–27—Department of Pathophysiology and Transplantation, Università degli Studi di Milano); “Aldo Ravelli” Research Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy; Associazione Amici della Neurochirurgia del Policlinico di Milano A-Tono Onlus, Milan. Open access publishing facilitated by Universita degli Studi di Milano, as part of the Wiley - CRUI-CARE agreement. Ethical Compliance Statement: Ethical review and informed patient consent were not necessary for this work. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflict of Interest: No specific funding was received for this work. LGR reports a relationship with Newronika that includes: travel reimbursement. ML reports a relationship with Newronika that includes: equity or stocks. IUI reports a relationship with Newronika that includes: equity or stocks. FC reports a relationship with Newronika that includes: equity or stocks. Financial Disclosures for the Previous 12 Months: The authors declare that there are no additional disclosures to report. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
  • Exploring the relationship between dystonia and STN-DBS in Parkinson’s disease: insights from a single-centre cohort
    Luigi G. Remore, Delia Gagliardi, Linda Borellini, Alfonso Fasano, Valeria Lo Faso, Filippo Cogiamanian, Enrico Mailand, Gloria Valcamonica, Elena Pirola, Luigi Schisano, Antonella M. Ampollini, Giulio A. Bertani, Giorgio Fiore, Antonio D’Ammando, Leonardo Tariciotti, Giovanni Marfia, Stefania Elena Navone, Sergio Barbieri, Marco Locatelli
    Neurological Sciences, 2025
    Introduction Motor side effects may emerge after deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson’s disease (PD) patients. Out of 60 PD patients, we observed 16 patients displaying de novo dystonic symptoms after the implantation and 11 dystonic PD patients without benefit from the stimulation. We hypothesized that a common neural pathway may cause dystonia in both conditions. Our study aims to investigate the clinical and connectivity substrates of dystonia after STN-DBS. Methods We divided our cohort into four groups: 16 patients displaying dystonia after STN-DBS, 11 patients with previously known dystonia not improving after surgery, 14 patients with dystonic symptoms relieved by the stimulation and 19 controls who never experienced dystonia. MANOVA was used to compare clinical data and the distance of the active contact center from the STN border among the four groups. Finally, we reconstructed the “sour” spots for dystonic symptoms and the associated structural and functional connectivity using a Parkinsonian normative connectome. Results De novo dystonic and not-improved dystonic patients had a statistically significant longer PD duration before surgery (p = 0.001) and a greater active contact-STN distance (p &lt; 0.001). Moreover, the “sour” spots were similar in both groups and structural and functional connectivity profiles were associated with brain areas correlated with dystonia pathophysiology (cerebellum, midbrain, parietal and temporal cortices). Conclusions We formulated a two-hit model for dystonia after STN-DBS: a clinical feature of Parkinsonian patients causes predisposing altered plasticity contributing to dystonic symptoms development when coupled with the stimulation of dystonia-related subcortical and cortical structures.
  • Regression-based thresholds to detect clinical changes in verbal fluency after STN-DBS in Parkinson's disease
    Francesca Mameli, Edoardo Nicolò Aiello, Fabiana Ruggiero, Eleonora Zirone, Linda Borellini, Filippo Cogiamanian, Angelica Marfoli, Federica Solca, Barbara Poletti, Nicola Ticozzi, Sergio Barbieri, Alberto Priori, Roberta Ferrucci
    Parkinsonism and Related Disorders, 2025
  • Deep Brain Stimulation in Parkinson Disease: A Switch for On/Off Dystonia
    Valeria Lo Faso, Luigi Schisano, Luigi Gianmaria Remore, Leonardo Tariciotti, Giorgio Fiore, Gloria Valcamonica, Linda Borellini, Filippo Cogiamanian, Antonio D'Ammando, Elena Pirola, Antonella Ampollini, Giovanni Marfia, Marco Locatelli
    World Neurosurgery, 2025
    BACKGROUND: Dystonia is common in Parkinson disease patients, affecting about 30% of them. Bilateral subthalamic nucleus deep brain stimulation (DBS) can sometimes lead to dystonia, but this relationship is not well understood. Our aim was to provide a better understanding of dystonia's causes and its connection to DBS. METHODS: We conducted a retrospective analysis of clinical data from 80 Parkinson disease patients who underwent bilateral subthalamic nucleus stimulation, focusing on dystonia before and after surgery and its relation to medication state (on-dystonia/off-dystonia). RESULTS: After DBS, off-dystonia had a higher recovery rate than on-dystonia (43.5% vs. 9.1%). Among patients suffering for on-dystonia, 74.4% had it for the first time after surgery; these patients assumed higher doses of levodopa before DBS. CONCLUSIONS: Patients with off-dystonia before surgery tend to improve after DBS. Otherwise, DBS could have the role of "additive boost" in the process of sensitization of striato-pallidal pathways and lead to on-dystonia in particular patients.
  • Co-Design of a Mixed Reality Application to Support Freezing of Gait Rehabilitation
    Eleonora Chitti, D. Andrea Montereale, Angelica De Sandi, Enrico Mailland, Linda Borrellini, Filippo Cogiamanian, Denise Mellace, Angelica Marfoli, Carmelo Campo, Carlo Manzoni, Roberta Ferrucci, N. Alberto Borghese
    Segah 2025 2025 IEEE 13th Conference on Serious Games and Applications for Health, 2025
    Freezing of Gait (FoG) is a common motor impairment in Parkinson's disease, affecting mobility and increasing fall risk. Traditional rehabilitation methods using physical therapy and, visual or auditory, cueing have demonstrated benefits but can be limited in adaptability and accessibility. Recent advancements in Mixed Reality (MR) provide new opportunities for rehabilitation. MR preserves spatial awareness by integrating digital elements into the real world while offering real-time adaptability in therapeutic settings. This study presents a co-designed MR rehabilitation platform with training exercises for FoG therapy. The system comprises an Oculus Quest 3 application and a Companion tablet app for real-time exercise personalization and cue activation. Nine medical professionals were involved in the whole process and two patients with Parkinson's disease were involved in refining the platform. Three iterative workshops led to key refinements enhancing usability. Initial sessions defined core FoG rehabilitation needs addressed with two exercises: obstacle avoidance and corridor crossing, and through the design of visual and auditory cues to help patients in training. Usability improvements included a Companion tablet app for real-time exercise customization, refined and personalized cueing. These updates reduced discomfort and enhanced adaptability in rehabilitation. This study highlights the potential of MR for FoG rehabilitation and presents a system that supports real-time adaptive cueing. Future research should explore a wider usability study, and the implementation of additional cueing techniques to address diverse patient needs across different stages of FoG.
  • Can total electrical energy (TEED) after subthalamic DBS alter verbal fluency in Parkinson's disease patients? A preliminary evidence
    Fabiana Ruggiero, Francesca Mameli, Edoardo Nicolò Aiello, Eleonora Zirone, Filippo Cogiamanian, Linda Borellini, Elena Pirola, Antonella Ampollini, Barbara Poletti, Angelica De Sandi, Marco Prenassi, Sara Marceglia, Nicola Ticozzi, Vincenzo Silani, Marco Locatelli, Giordano D’Urso, Sergio Barbieri, Alberto Priori, Roberta Ferrucci
    CNS Spectrums, 2024
  • RAB32 mutation in Parkinson's disease [2]
    Edoardo Monfrini, Raffaella Minardi, Franco Valzania, Giovanna Calandra-Buonaura, Paola Mandich, Alessio Di Fonzo, Valerio Carelli, Andrea Gaudio, Agata Fant, Ilaria Palmieri, Valentina Fioravanti, Francesco Cavallieri, Francesca Di Biasio, Alessia Fiorentino, Manuela Vecchi, Paola Origone, Sara Trova, Giovanni Rizzo, Giulia Giannini, Stefano Gambardella, Micol Avenali, Stefano Gustincich, Pietro Cortelli, Fabio Blandini, Enza Maria Valente
    Lancet Neurology, 2024
  • The Protective Role of Cognitive Reserve: A Preliminary Study on Parkinsonian Patients Undergoing Deep Brain Stimulation
    Eleonora Zirone, Fabiana Ruggiero, Maria Takeko Molisso, Roberta Ferrucci, Angelica De Sandi, Angelica Marfoli, Denise Mellace, Filippo Cogiamanian, Linda Borellini, Enrico Mailland, Elena Pirola, Antonella Ampollini, Marco Locatelli, Sergio Barbieri, Francesca Mameli
    Journal of Clinical Medicine, 2024
  • The role of SWI sequence during the preoperative targeting of the subthalamic nucleus for deep brain stimulation in Parkinson's disease: A retrospective cohort study
    Luigi Gianmaria Remore, Leonardo Tariciotti, Giorgio Fiore, Elena Pirola, Linda Borellini, Filippo Cogiamanian, Antonella Maria Ampollini, Luigi Schisano, Dario Gagliano, Stefano Borsa, Mauro Pluderi, Giulio Andrea Bertani, Sergio Barbieri, Marco Locatelli
    World Neurosurgery X, 2024
  • The Clinical Spectrum of ANO3—Report of a New Family and Literature Review
    Marco Percetti, Michela Zini, Paola Soliveri, Filippo Cogiamanian, Mariarosa Ferrara, Eva Orunesu, Alessandra Ranghetti, Carlo Ferrarese, Gianni Pezzoli, Barbara Garavaglia, Ioannis Ugo Isaias, Giorgio Sacilotto
    Movement Disorders Clinical Practice, 2024
  • Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort
    Micol Avenali, Roberta Zangaglia, Giada Cuconato, Ilaria Palmieri, Alberto Albanese, Carlo Alberto Artusi, Marco Bozzali, Giovanna Calandra-Buonaura, Francesco Cavallieri, Roberto Cilia, Antoniangela Cocco, Filippo Cogiamanian, Fabiana Colucci, Pietro Cortelli, Alessio Di Fonzo, Roberto Eleopra, Giulia Giannini, Alberto Imarisio, Gabriele Imbalzano, Claudia Ledda, Leonardo Lopiano, Maria Chiara Malaguti, Francesca Mameli, Raffaella Minardi, Pierfrancesco Mitrotti, Edoardo Monfrini, Francesca Spagnolo, Cristina Tassorelli, Francesca Valentino, Franco Valzania, Claudio Pacchetti, Enza Maria Valente
    Journal of Neurology Neurosurgery and Psychiatry, 2023
  • Energy Delivered by Subthalamic Deep Brain Stimulation for Parkinson Disease Correlates With Depressive Personality Trait Shift
    Francesca Mameli, Fabiana Ruggiero, Michelangelo Dini, Sara Marceglia, Marco Prenassi, Linda Borellini, Filippo Cogiamanian, Elena Pirola, Luigi Gianmaria Remore, Giorgio Fiore, Maria Rita Reitano, Natale Maiorana, Barbara Poletti, Marco Locatelli, Sergio Barbieri, Alberto Priori, Roberta Ferrucci
    Neuromodulation, 2023
  • Case report: Clinical and molecular characterization of two siblings affected by Brody myopathy
    Daniele Velardo, Sara Antognozzi, Martina Rimoldi, Serena Pagliarani, Filippo Cogiamanian, Sergio Barbieri, Stefania Corti, Giacomo Pietro Comi, Dario Ronchi
    Frontiers in Neurology, 2023
  • Author Correction: Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease (npj Parkinson's Disease, (2021), 7, 1, (88), 10.1038/s41531-021-00229-z)
    Tommaso Bocci, Marco Prenassi, Mattia Arlotti, Filippo Maria Cogiamanian, Linda Borellini, Elena Moro, Andres M. Lozano, Jens Volkmann, Sergio Barbieri, Alberto Priori, Sara Marceglia
    Npj Parkinson S Disease, 2022
  • Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspective
    Giorgio Fiore, Giorgia Abete-Fornara, Arianna Forgione, Leonardo Tariciotti, Mauro Pluderi, Stefano Borsa, Cristina Bana, Filippo Cogiamanian, Maurizio Vergari, Valeria Conte, Manuela Caroli, Marco Locatelli, Giulio Andrea Bertani
    Frontiers in Oncology, 2022
  • Peri-lead edema and local field potential correlation in post-surgery subthalamic nucleus deep brain stimulation patients
    Marco Prenassi, Linda Borellini, Tommaso Bocci, Elisa Scola, Sergio Barbieri, Alberto Priori, Roberta Ferrucci, Filippo Cogiamanian, Marco Locatelli, Paolo Rampini, Maurizio Vergari, Stefano Pastore, Bianca Datola, Sara Marceglia
    Frontiers in Human Neuroscience, 2022
  • Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease
    Tommaso Bocci, Marco Prenassi, Mattia Arlotti, Filippo Maria Cogiamanian, Linda Borrellini, Elena Moro, Andres M. Lozano, Jens Volkmann, Sergio Barbieri, Alberto Priori, Sara Marceglia
    Npj Parkinson S Disease, 2021
  • Subclinical myopathic changes in COVID-19
    Davide Villa, Gianluca Ardolino, Linda Borellini, Filippo Cogiamanian, Maurizio Vergari, Valeria Savojardo, Flora Peyvandi, Sergio Barbieri
    Neurological Sciences, 2021
  • The Relationship Between Electrical Energy Delivered by Deep Brain Stimulation and Levodopa-Induced Dyskinesias in Parkinson's Disease: A Retrospective Preliminary Analysis
    Marco Prenassi, Mattia Arlotti, Linda Borellini, Tommaso Bocci, Filippo Cogiamanian, Marco Locatelli, Paolo Rampini, Sergio Barbieri, Alberto Priori, Sara Marceglia
    Frontiers in Neurology, 2021
  • Effective Connectivity During Rest and Music Listening: An EEG Study on Parkinson’s Disease
    Eleonora Maggioni, Federica Arienti, Stella Minella, Francesca Mameli, Linda Borellini, Martina Nigro, Filippo Cogiamanian, Anna Maria Bianchi, Sergio Cerutti, Sergio Barbieri, Paolo Brambilla, Gianluca Ardolino
    Frontiers in Aging Neuroscience, 2021
  • A Novel Homozygous VPS11 Variant May Cause Generalized Dystonia
    Edoardo Monfrini, Filippo Cogiamanian, Sabrina Salani, Letizia Straniero, Gigliola Fagiolari, Manuela Garbellini, Emma Carsana, Linda Borellini, Fabio Biella, Maurizio Moggio, Nereo Bresolin, Stefania Corti, Stefano Duga, Giacomo P. Comi, Massimo Aureli, Alessio Di Fonzo
    Annals of Neurology, 2021
  • Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: An update
    Linda Borellini, Filippo Cogiamanian, Gianluca Ardolino
    Parkinsonism and Related Disorders, 2021
  • Spinal direct current stimulation (tsDCS) in hereditary spastic paraplegias (HSP): A sham-controlled crossover study
    Gianluca Ardolino, Tommaso Bocci, Martina Nigro, Maurizio Vergari, Alessio Di Fonzo, Sara Bonato, Filippo Cogiamanian, Francesca Cortese, Ilaria Cova, Sergio Barbieri, Alberto Priori
    Journal of Spinal Cord Medicine, 2021
  • GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort
    Simona Petrucci, Monia Ginevrino, Ilaria Trezzi, Edoardo Monfrini, Lucia Ricciardi, Alberto Albanese, Micol Avenali, Paolo Barone, Anna Rita Bentivoglio, Vincenzo Bonifati, Francesco Bove, Laura Bonanni, Livia Brusa, Cristina Cereda, Giovanni Cossu, Chiara Criscuolo, Giovanna Dati, Anna De Rosa, Roberto Eleopra, Giovanni Fabbrini, Laura Fadda, Manuela Garbellini, Brigida Minafra, Marco Onofrj, Claudio Pacchetti, Ilaria Palmieri, Maria Teresa Pellecchia, Martina Petracca, Marina Picillo, Antonio Pisani, Annamaria Vallelunga, Roberta Zangaglia, Alessio Di Fonzo, Francesca Morgante, Enza Maria Valente, Maria Concetta Altavista, Marianna Amboni, Gianluca Ardolino, Alfredo Berardelli, Filippo Cogiamanian, Carlo Colosimo, Danilo Costanti, Giuseppe De Michele, Carlo Di Bonaventura, Giulia Di Lazzaro, Vincenzo Di Lazzaro, Antonio Emanuele Elia, Roberto Erro, Gina Ferrazzano, Andrea Guerra, Tamara Ialongo, Maria Chiara Malaguti, Marta Melis, Elena Moro, Valentina Oppo, Donatella Ottaviani, Silvio Peluso, Maria Luisa Quadri, Luigi Michele Romito, Marianna Sarchioto, Tommaso Schirinzi, Chiara Sorbera, Alessandro Stefani, Astrid Thomas, Maria Luisa Valente, Giampiero Volpe, and
    Movement Disorders, 2020
  • Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?
    Margherita Fabbri, Maurizio Zibetti, Mario Giorgio Rizzone, Giulia Giannini, Linda Borellini, Alessandro Stefani, Francesco Bove, Andrea Bruno, Giovanna Calandra‐Buonaura, Nicola Modugno, Carla Piano, Antonella Peppe, Gianluca Ardolino, Alberto Romagnolo, Carlo Alberto Artusi, Paola Berchialla, Elisa Montanaro, Pietro Cortelli, Romito Luigi, Roberto Eleopra, Brigida Minafra, Claudio Pacchetti, Tommaso Tufo, Filippo Cogiamanian, Leonardo Lopiano
    Movement Disorders, 2020
  • Long-term follow-up of neuropsychological functions in patients with high grade gliomas: can cognitive status predict patient’s outcome after surgery?
    Barbara Zarino, Andrea Di Cristofori, Giorgia Abete Fornara, Giulio Andrea Bertani, Marco Locatelli, Manuela Caroli, Paolo Rampini, Filippo Cogiamanian, Davide Crepaldi, Giorgio Carrabba
    Acta Neurochirurgica, 2020
  • Peri-lead edema after deep brain stimulation surgery for Parkinson's disease: a prospective magnetic resonance imaging study
    L. Borellini, G. Ardolino, G. Carrabba, M. Locatelli, P. Rampini, S. Sbaraini, E. Scola, S. Avignone, F. Triulzi, S. Barbieri, F. Cogiamanian
    European Journal of Neurology, 2019
  • Ophthalmoplegia due to Miller Fisher syndrome in a patient with myasthenia gravis
    Roberta Brusa, Irene Faravelli, Delia Gagliardi, Francesca Magri, Filippo Cogiamanian, Domenica Saccomanno, Claudia Cinnante, Eleonora Mauri, Elena Abati, Nereo Bresolin, Stefania Corti, Giacomo Pietro Comi
    Frontiers in Neurology, 2019
  • Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
    Giacomo Monzio Compagnoni, Giulio Kleiner, Andreina Bordoni, Francesco Fortunato, Dario Ronchi, Sabrina Salani, Marianna Guida, Corrado Corti, Irene Pichler, Christian Bergamini, Romana Fato, Maria Teresa Pellecchia, Annamaria Vallelunga, Francesca Del Sorbo, Antonio Elia, Chiara Reale, Barbara Garavaglia, Gabriele Mora, Alberto Albanese, Filippo Cogiamanian, Gianluca Ardolino, Nereo Bresolin, Stefania Corti, Giacomo P. Comi, Catarina M. Quinzii, Alessio Di Fonzo
    Biochimica Et Biophysica Acta Molecular Basis of Disease, 2018
  • Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
    Mattia Arlotti, Sara Marceglia, Guglielmo Foffani, Jens Volkmann, Andres M. Lozano, Elena Moro, Filippo Cogiamanian, Marco Prenassi, Tommaso Bocci, Francesca Cortese, Paolo Rampini, Sergio Barbieri, Alberto Priori
    Neurology, 2018
  • Neurophysiology of the pelvic floor in clinical practice: A systematic literature review
    F Bianchi
    Functional Neurology, 2017
  • Mutations in TMEM230 are rare in autosomal dominant Parkinson's disease
    Gabriele Buongarzone, Edoardo Monfrini, Giulia Franco, Ilaria Trezzi, Linda Borellini, Emanuele Frattini, Valentina Melzi, Anna Chiara Di Caprio, Dario Ronchi, Giacomo Monzio Compagnoni, Filippo Cogiamanian, Gianluca Ardolino, Nereo Bresolin, Giacomo P. Comi, Stefania Corti, Alessio Di Fonzo
    Parkinsonism and Related Disorders, 2017
  • Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: A case report
    Linda Borellini, Filippo Cogiamanian, Giorgio Carrabba, Marco Locatelli, Paolo Rampini, Alessio Di Fonzo, Cristina Bana, Sergio Barbieri, Gianluca Ardolino
    Parkinsonism and Related Disorders, 2017
  • Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients
    Manuela Rosa, Mattia Arlotti, Sara Marceglia, Filippo Cogiamanian, Gianluca Ardolino, Alessio Di Fonzo, Leonardo Lopiano, Emma Scelzo, Aristide Merola, Marco Locatelli, Paolo M. Rampini, Alberto Priori
    Movement Disorders, 2017
  • Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)
    Jean-Pascal Lefaucheur, Andrea Antal, Samar S. Ayache, David H. Benninger, Jérôme Brunelin, Filippo Cogiamanian, Maria Cotelli, Dirk De Ridder, Roberta Ferrucci, Berthold Langguth, Paola Marangolo, Veit Mylius, Michael A. Nitsche, Frank Padberg, Ulrich Palm, Emmanuel Poulet, Alberto Priori, Simone Rossi, Martin Schecklmann, Sven Vanneste, Ulf Ziemann, Luis Garcia-Larrea, Walter Paulus
    Clinical Neurophysiology, 2017
  • Abnormal sexuality in Parkinson's disease: fact or fancy?
    Roberta Ferrucci, Marta Panzeri, Lucia Ronconi, Gianluca Ardolino, Filippo Cogiamanian, Sergio Barbieri, Paolo Barone, Laura Bertolasi, Alessandro Padovani, Alberto Priori
    Journal of the Neurological Sciences, 2016
  • Role of Intraoperative Neurophysiologic Monitoring in the Resection of Thalamic Astrocytomas
    Giorgio Carrabba, Giulio Bertani, Filippo Cogiamanian, Gianluca Ardolino, Barbara Zarino, Andrea Di Cristofori, Marco Locatelli, Manuela Caroli, Paolo Rampini
    World Neurosurgery, 2016
  • Mutational analysis of COQ2 in patients with MSA in Italy
    Dario Ronchi, Ernesto Di Biase, Giulia Franco, Valentina Melzi, Francesca Del Sorbo, Antonio Elia, Chiara Barzaghi, Barbara Garavaglia, Christian Bergamini, Romana Fato, Gabriele Mora, Roberto Del Bo, Francesco Fortunato, Linda Borellini, Ilaria Trezzi, Giacomo Monzio Compagnoni, Edoardo Monfrini, Emanuele Frattini, Sara Bonato, Filippo Cogiamanian, Gianluca Ardolino, Alberto Priori, Nereo Bresolin, Stefania Corti, Giacomo Pietro Comi, Alessio Di Fonzo
    Neurobiology of Aging, 2016
  • Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease
    Roberta Ferrucci, Francesca Cortese, Marta Bianchi, Dario Pittera, Rosanna Turrone, Tommaso Bocci, Barbara Borroni, Maurizio Vergari, Filippo Cogiamanian, Gianluca Ardolino, Alessio Di Fonzo, Alessandro Padovani, Alberto Priori
    Cerebellum, 2016
  • An unexpected target of spinal direct current stimulation: Interhemispheric connectivity in humans
    Tommaso Bocci, Matteo Caleo, Beatrice Vannini, Maurizio Vergari, Filippo Cogiamanian, Simone Rossi, Alberto Priori, Ferdinando Sartucci
    Journal of Neuroscience Methods, 2015
  • Corrigendum to Ethical safety of deep brain stimulation: A study on moral decision-making in Parkinson's disease [Park. Relat. Disord., 21, (2015), 709-716] DOI: 10.1016/j.parkreldis.2015.04.011
    Manuela Fumagalli, Sara Marceglia, Filippo Cogiamanian, Gianluca Ardolino, Marta Picascia, Sergio Barbieri, Gabriella Pravettoni, Claudio Pacchetti, Alberto Priori
    Parkinsonism and Related Disorders, 2015
  • Ethical safety of deep brain stimulation: A study on moral decision-making in Parkinson's disease
    Manuela Fumagalli, Sara Marceglia, Filippo Cogiamanian, Gianluca Ardolino, Marta Picascia, Sergio Barbieri, Gabriella Pravettoni, Claudio Pacchetti, Alberto Priori
    Parkinsonism and Related Disorders, 2015
  • Adaptive deep brain stimulation in a freely moving parkinsonian patient
    Manuela Rosa, Mattia Arlotti, Gianluca Ardolino, Filippo Cogiamanian, Sara Marceglia, Alessio Di Fonzo, Francesca Cortese, Paolo M. Rampini, Alberto Priori
    Movement Disorders, 2015
  • Abnormal local field potentials precede clinical complications after DBS surgery for Parkinson's disease: A case report
    Francesca Cortese, Manuela Rosa, Mattia Arlotti, Filippo Cogiamanian, Gianluca Ardolino, Paolo Rampini, Giorgio Carrabba, Marco Locatelli, Vincenzo Levi, Alberto Priori
    Clinical Neurophysiology, 2015
  • Transcutaneous spinal direct current stimulation modulates human corticospinal system excitability
    Tommaso Bocci, Sara Marceglia, Maurizio Vergari, Valeria Cognetto, Filippo Cogiamanian, Ferdinando Sartucci, Alberto Priori
    Journal of Neurophysiology, 2015
  • Bilateral Parkinsonism: When to image?
    Vincenzo Levi, Giulio Andrea Bertani, Giorgio Carrabba, Marco Locatelli, Filippo Cogiamanian, Paolo Rampini
    Practical Neurology, 2015
  • Cathodal transcutaneous spinal direct current stimulation (tsDCS) improves motor unit recruitment in healthy subjects
    Tommaso Bocci, Beatrice Vannini, Antonio Torzini, Andrea Mazzatenta, Maurizio Vergari, Filippo Cogiamanian, Alberto Priori, Ferdinando Sartucci
    Neuroscience Letters, 2014
  • Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis
    Roberta Ferrucci, Maurizio Vergari, Filippo Cogiamanian, Tommaso Bocci, Matteo Ciocca, Emanuele Tomasini, Milena De Riz, Elio Scarpini, Alberto Priori
    Neurorehabilitation, 2014
  • Modeling the current density generated by transcutaneous spinal direct current stimulation (tsDCS)
    Marta Parazzini, Serena Fiocchi, Ilaria Liorni, Elena Rossi, Filippo Cogiamanian, Maurizio Vergari, Alberto Priori, Paolo Ravazzani
    Clinical Neurophysiology, 2014
  • Transcranial Direct Current Stimulation (tDCS) and lymphocytes
    G. Ardolino, E. Scelzo, F. Cogiamanian, P. Bonara, A. Nozza, M. Rosa, S. Garlaschi, S. Barbieri, A. Priori
    Brain Stimulation, 2014
  • Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study
    Michele Tinazzi, Giovanni Abbruzzese, Angelo Antonini, Roberto Ceravolo, Giovanni Fabbrini, Patrizia Lessi, Paolo Barone
    Parkinsonism and Related Disorders, 2013
  • Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items"
    On behalf of the REASON study group, G. Fabbrini, G. Abbruzzese, P. Barone, A. Antonini, M. Tinazzi, G. Castegnaro, S. Rizzoli, D. E. Morisky, P. Lessi, R. Ceravolo
    Neurological Sciences, 2013
  • Transcranial direct current stimulation (tDCS) and language
    A. Monti, R. Ferrucci, M. Fumagalli, F. Mameli, F. Cogiamanian, G. Ardolino, A. Priori
    Journal of Neurology Neurosurgery and Psychiatry, 2013
  • The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in parkinson's disease
    Gaia Giannicola, Manuela Rosa, Sara Marceglia, Emma Scelzo, Lorenzo Rossi, Domenico Servello, Claudia Menghetti, Claudio Pacchetti, Roberta Zangaglia, Marco Locatelli, Elena Caputo, Filippo Cogiamanian, Gianluca Ardolino, Sergio Barbieri, Alberto Priori
    Neurosignals, 2013
  • Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease
    Gaia Giannicola, Manuela Rosa, Domenico Servello, Claudia Menghetti, Giorgio Carrabba, Claudio Pacchetti, Roberta Zangaglia, Filippo Cogiamanian, Emma Scelzo, Sara Marceglia, Lorenzo Rossi, Alberto Priori
    Experimental Neurology, 2012
  • Increased short latency afferent inhibition after anodal transcranial direct current stimulation
    Emma Scelzo, Gaia Giannicola, Manuela Rosa, Matteo Ciocca, Gianluca Ardolino, Filippo Cogiamanian, Roberta Ferrucci, Manuela Fumagalli, Francesca Mameli, Sergio Barbieri, Alberto Priori
    Neuroscience Letters, 2011
  • Transcutaneous spinal cord direct current stimulation inhibits the lower limb nociceptive flexion reflex in human beings
    Filippo Cogiamanian, Maurizio Vergari, Elena Schiaffi, Sara Marceglia, Gianluca Ardolino, Sergio Barbieri, Alberto Priori
    Pain, 2011
  • The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease
    Gaia Giannicola, Sara Marceglia, Lorenzo Rossi, Simona Mrakic-Sposta, Paolo Rampini, Filippo Tamma, Filippo Cogiamanian, Sergio Barbieri, Alberto Priori
    Experimental Neurology, 2010
  • Treatment of Frey's syndrome with botulinum toxin type B
    Giovanna Cantarella, Alessandra Berlusconi, Vincenzo Mele, Filippo Cogiamanian, Sergio Barbieri
    Otolaryngology Head and Neck Surgery, 2010
  • Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
    Alberto Lerario, Filippo Cogiamanian, Chiara Marchesi, Marzia Belicchi, Nereo Bresolin, Laura Porretti, Yvan Torrente
    BMC Musculoskeletal Disorders, 2010
  • Non-invasive brain stimulation for the management of arterial hypertension
    F. Cogiamanian, A.R. Brunoni, P.S. Boggio, F. Fregni, M. Ciocca, A. Priori
    Medical Hypotheses, 2010
  • Novel nonpharmacologic perspectives for the treatment of task-specific focal hand dystonia
    Filippo Cogiamanian, Sergio Barbieri, Alberto Priori
    Journal of Hand Therapy, 2009
  • Effect of spinal transcutaneous direct current stimulation on somatosensory evoked potentials in humans
    Filippo Cogiamanian, Maurizio Vergari, Francesca Pulecchi, Sara Marceglia, Alberto Priori
    Clinical Neurophysiology, 2008
  • Cerebellar transcranial direct current stimulation impairs the practice-dependent proficiency increase in working memory
    R. Ferrucci, S. Marceglia, M. Vergari, F. Cogiamanian, S. Mrakic-Sposta, F. Mameli, S. Zago, S. Barbieri, A. Priori
    Journal of Cognitive Neuroscience, 2008
  • Transcranial direct current stimulation improves recognition memory in Alzheimer disease
    R. Ferrucci, F. Mameli, I. Guidi, S. Mrakic-Sposta, M. Vergari, S. Marceglia, F. Cogiamanian, S. Barbieri, E. Scarpini, A. Priori
    Neurology, 2008
  • Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease
    L. Rossi, S. Marceglia, G. Foffani, F. Cogiamanian, F. Tamma, P. Rampini, S. Barbieri, F. Bracchi, A. Priori
    Brain Research Bulletin, 2008
  • Extracellular spike microrecordings from the subthalamic area in Parkinson's disease
    Simona Mrakic-Sposta, Sara Marceglia, Marcello Egidi, Giorgio Carrabba, Paolo Rampini, Marco Locatelli, Guglielmo Foffani, Ettore Accolla, Filippo Cogiamanian, Filippo Tamma, Sergio Barbieri, Alberto Priori
    Journal of Clinical Neuroscience, 2008
  • Improved naming after transcranial direct current stimulation in aphasia
    A Monti, F Cogiamanian, S Marceglia, R Ferrucci, F Mameli, S Mrakic-Sposta, M Vergari, S Zago, A Priori
    Journal of Neurology Neurosurgery and Psychiatry, 2008
  • Lie-specific involvement of dorsolateral prefrontal cortex in deception
    A. Priori, F. Mameli, F. Cogiamanian, S. Marceglia, M. Tiriticco, S. Mrakic-Sposta, R. Ferrucci, S. Zago, D. Polezzi, G. Sartori
    Cerebral Cortex, 2008
  • Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: A 1H-MRS study
    M. Rango, F. Cogiamanian, S. Marceglia, B. Barberis, A. Arighi, P. Biondetti, A. Priori
    Magnetic Resonance in Medicine, 2008
  • Interaction between rhythms in the human basal ganglia: Application of bispectral analysis to local field potentials
    Sara Marceglia, Anna Maria Bianchi, Giuseppe Baselli, Guglielmo Foffani, Filippo Cogiamanian, Nicola Modugno, Simona Mrakic-Sposta, Alberto Priori, Sergio Cerutti
    IEEE Transactions on Neural Systems and Rehabilitation Engineering, 2007
  • Improved isometric force endurance after transcranial direct current stimulation over the human motor cortical areas
    F. Cogiamanian, S. Marceglia, G. Ardolino, S. Barbieri, A. Priori
    European Journal of Neuroscience, 2007
  • Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation
    Ettore Accolla, Elena Caputo, Filippo Cogiamanian, Filippo Tamma, Simona Mrakic‐Sposta, Sara Marceglia, Marcello Egidi, Paolo Rampini, Marco Locatelli, Alberto Priori
    Movement Disorders, 2007
  • Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients
    Y. Torrente, M. Belicchi, C. Marchesi, G. D'antona, F. Cogiamanian, F. Pisati, M. Gavina, R. Giordano, R. Tonlorenzi, G. Fagiolari, C. Lamperti, L. Porretti, R. Lopa, M. Sampaolesi, L. Vicentini, N. Grimoldi, F. Tiberio, V. Songa, P. Baratta, A. Prelle, L. Forzenigo, M. Guglieri, O. Pansarasa, C. Rinaldi, V. Mouly, G. S. Butler-Browne, G. P. Comi, P. Biondetti, M. Moggio, S. M. Gaini, N. Stocchetti, A. Priori, M. G. D'angelo, A. Turconi, R. Bottinelli, G. Cossu, P. Rebulla, N. Bresolin
    Cell Transplantation, 2007
  • Gender-related differences in the human subthalamic area: A local field potential study
    S. Marceglia, S. Mrakic‐Sposta, G. Foffani, F. Cogiamanian, E. Caputo, M. Egidi, S. Barbieri, A. Priori
    European Journal of Neuroscience, 2006
  • Pathophysiology of spasticity
    A. Priori, F. Cogiamanian, S. Mrakic-Sposta
    Neurological Sciences, 2006
  • Alzheimer's disease: From molecular pathogenesis to innovative therapies
    Elio Scarpini, Filippo Cogiamanian
    Expert Review of Neurotherapeutics, 2003
  • Production of IL-6 by human myoblasts stimulated with Aβ: Relevance in the pathogenesis of IBM
    P. Baron, D. Galimberti, L. Meda, E. Scarpini, G. Conti, F. Cogiamanian, G. Scarlato
    Neurology, 2001